Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone.
about
Stem cell therapy for chronic ischaemic heart disease and congestive heart failureProgramming and reprogramming a human heart cellCell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsXenotransplantation of Human Cardiomyocyte Progenitor Cells Does Not Improve Cardiac Function in a Porcine Model of Chronic Ischemic Heart Failure. Results from a Randomized, Blinded, Placebo Controlled TrialAdult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled TrialsStem cell therapy for chronic ischaemic heart disease and congestive heart failure.Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease.Cell-based therapy for heart disease: a clinically oriented perspectiveEarly increase in myocardial perfusion after stem cell therapy in patients undergoing incomplete coronary artery bypass surgery.Laser-supported CD133+ cell therapy in patients with ischemic cardiomyopathy: initial results from a prospective phase I multicenter trial.Additive value of adult bone-marrow-derived cell transplantation to conventional revascularization in chronic ischemic heart disease: a systemic review and meta-analysis.Are surgical trials with negative results being interpreted correctly?Clinical trials of cardiac repair with adult bone marrow- derived cells.Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system.Efficacy and safety of bone marrow cell transplantation for chronic ischemic heart disease: a meta-analysis.Intraoperative stem cell therapyIntramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up.Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: a meta-analysis.Stem cell therapy for heart diseases.Cell delivery routes for stem cell therapy to the heart: current and future approaches.Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis.New cell therapies in cardiology.Choice of cell-delivery route for successful cell transplantation therapy for the heart.Stem cell therapy for heart disease.The role of large animal studies in cardiac regenerative therapy concise review of translational stem cell research.Transplantation of bone marrow stem cells during cardiac surgery.Cardiac tissue engineering and regeneration using cell-based therapyCellular Therapy for Heart Failure.Autologous bone marrow cells and ischemic cardiomyopathy.Moving beyond surrogate endpoints in cell therapy trials for heart disease.Safety and feasibility of intramyocardial versus intracoronary delivery of autologous cell therapy in advanced heart failure: the REGENERATE-IHD pilot study.Comparative analysis of apoptotic resistance of mesenchymal stem cells isolated from human bone marrow and adipose tissue
P2860
Q24194988-607BEA54-D187-4F1F-965D-433C99CC5FABQ26823933-07D79A16-44CB-40C4-A034-0A614DB4EA3FQ27001159-D27144BF-6A74-4121-8D66-D0AADF668614Q27336487-FAB6BC53-7852-4551-BC4E-83A14DCCF57FQ28082162-53163F50-3977-4A3C-87BC-E7A24D57448DQ30239945-10A6D632-E0EC-413A-9A2D-C75D7DA7CA4AQ33490304-97A6B5CA-743A-442F-8E8B-E6AB825D8BAFQ33713519-6840FA34-5CEA-4934-B054-5549159D187EQ33742308-0DC45E30-EBE6-43FF-A5EE-7780EB1D5F2CQ33855567-5803D887-29E3-41FB-A255-AC1AC5E1BBB5Q34043802-01B76108-965D-48A2-A111-035AF3BD0F10Q34193301-EE2A4023-DC9B-490B-8DF0-6DBC466BBB7FQ34786321-0209EC27-D4A6-405A-A2C0-B4AACDAD7937Q35001392-E7F156DE-42CC-4C56-8745-26B39995646BQ35290282-80A5DA99-D252-42B3-A396-8E40BB8D2E15Q36822337-809D6F50-A716-4BA0-8674-B3E8F75A0561Q37216076-E6C44092-4091-438C-8734-8BA063FFBB4AQ37851149-6AD39904-4A5A-4BBC-BAF8-F214638444FAQ37877423-BA7E683B-FF2E-4868-8C54-FCF84445E7A4Q38014708-4E866ACF-EE95-4681-BDC8-4D52D51EDCCEQ38021450-E8FFEA8A-77E9-4C94-9EF3-C8964835A4ABQ38048838-FA3D9563-7A7A-4101-BF3C-C947929460CCQ38086843-6F12767D-96CD-4033-AE1F-24D413AC362FQ38114860-4B189E8F-B7ED-4AE6-865C-870FBF200BF1Q38138564-C2CBA0EE-FC55-49DA-B864-38B46B595E14Q38256645-617C3F27-56B2-459E-ADBF-49F54362B28BQ38497140-55138E53-DD4D-43DF-809E-1B1E85DCF99FQ38859871-3B1C165A-65AB-4937-9FE1-174579D00217Q39706274-9D776C33-9BA3-491C-AFC9-E5F7ABE6CA5EQ41891677-7DB30CB2-4C30-4434-BD45-F565DD954FC4Q48712903-87639FC4-419A-4B3B-BD44-5187DDDCBA23Q58914533-B43F8A10-8A71-4EA5-B9BD-48DF0C6586E5
P2860
Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Randomized, controlled trial o ...... during CABG versus CABG alone.
@ast
Randomized, controlled trial o ...... during CABG versus CABG alone.
@en
type
label
Randomized, controlled trial o ...... during CABG versus CABG alone.
@ast
Randomized, controlled trial o ...... during CABG versus CABG alone.
@en
prefLabel
Randomized, controlled trial o ...... during CABG versus CABG alone.
@ast
Randomized, controlled trial o ...... during CABG versus CABG alone.
@en
P2093
P356
P1476
Randomized, controlled trial o ...... during CABG versus CABG alone.
@en
P2093
Derek Chin
Francisco Leyva
Keng-Leong Ang
Lakshmi Srinivasan
Lincoln T Shenje
Manuel Galiñanes
Paul Foley
Shajil Chalil
Suzanne Stevens
P2860
P2888
P304
P356
10.1038/NCPCARDIO1321
P577
2008-08-19T00:00:00Z
P5875
P6179
1006444323